1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Powers of Buyers
4.3.3. Threat of Substitutes
4.3.4. Threat of New Entrants
4.3.5. Competitive Rivalry in Industry
4.4. Industry Value Chain Analysis
5. Therapeutic Drug Monitoring Market, by Methodology
5.1. Introduction
5.2. Spectrophotometry and Fluorimetry
5.3. Chromatography
5.4. Radio Immuno Assay (RAI)
5.5. Enzyme Immuno Assay
5.6. Fluorescence Polarization Immunoassay (FPIA)
6. Therapeutic Drug Monitoring Market, by Drug Categories
6.1. Introduction
6.2. Cardio active drugs
6.3. Antibiotics
6.4. Antidepressants
6.5. Antiepileptic Drugs
6.6. Bronchodilators
6.7. Immunosuppressants
6.8. Others
7. Therapeutic Drug Monitoring Market, by End-User Industry
7.1. Introduction
7.2. Hospital and Clinics
7.3. Diagnostics Centers
7.4. Research Institutes
8. Therapeutic Drug Monitoring Market, by Geography
8.1. Introduction
8.2. North America
8.2.1. North America Therapeutic Drug Monitoring Market Analysis, By Methodology Type
8.2.2. North America Therapeutic Drug Monitoring Market Analysis, By Drug Category
8.2.3. North America Therapeutic Drug Monitoring Market Analysis, By End-User Industry
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.2.4.4. Others
8.3. South America
8.3.1. South America Therapeutic Drug Monitoring Market Analysis, By Methodology Type
8.3.2. South America Therapeutic Drug Monitoring Market Analysis, By Drug Category
8.3.3. South America Therapeutic Drug Monitoring Market Analysis, By End-User Industry
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. Europe Therapeutic Drug Monitoring Market Analysis, By Methodology Type
8.4.2. Europe Therapeutic Drug Monitoring Market Analysis, By Drug Category
8.4.3. Europe Therapeutic Drug Monitoring Market Analysis, By End-User Industry
8.4.4. By Country
8.4.4.1. Germany
8.4.4.2. France
8.4.4.3. United Kingdom
8.4.4.4. Others
8.5. Middle East and Africa
8.5.1. Middle East and Africa Therapeutic Drug Monitoring Market Analysis, By Methodology Type
8.5.2. Middle East and Africa Therapeutic Drug Monitoring Market Analysis, By Drug Category
8.5.3. Middle East and Africa Therapeutic Drug Monitoring Market Analysis, By End-User Industry
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. South Africa
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. Asia Pacific Therapeutic Drug Monitoring Market Analysis, By Methodology Type
8.6.2. Asia Pacific Therapeutic Drug Monitoring Market Analysis, By Drug Category
8.6.3. Asia Pacific Therapeutic Drug Monitoring Market Analysis, By End-User Industry
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Others
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrative
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles
10.1. Abbott
10.2. Thermo Fisher Scientific
10.3. Alpco
10.4. Randox Laboratories Ltd.
10.5. Beckman Coulter Inc.
10.6. Roche Diagnostics
10.7. Pharmaceutical Products Development LLC
10.8. Chromsystems Instruments & Chemicals GmbH
10.9. Bio-Rad Laboratories Inc.
List of Figures
List of Tables